Company Filing History:
Years Active: 1985-1997
Title: The Innovative Contributions of Russell L. Barton
Introduction
Russell L. Barton is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 9 patents to his name, Barton has established himself as a key figure in his industry.
Latest Patents
Among his latest patents are groundbreaking innovations in antibody drug-conjugates. These immunoconjugates utilize antibodies or antigen-recognizing fragments of antibodies combined with monovalent cytotoxic drug derivatives. The technology employs β-alanine derived linkers, allowing the antibody or fragment to attach to the linker's carboxy group via an ester or amide group. The drug is then connected through the linker's 2-position methylene group. This innovative approach also includes intermediates, compositions, and methods of use.
Career Highlights
Russell L. Barton is currently associated with Eli Lilly and Company, where he continues to push the boundaries of medical science. His work has been instrumental in advancing therapeutic options for various diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Barton has collaborated with notable colleagues, including Gary A. Koppel and Stephen L. Briggs. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Russell L. Barton is a distinguished inventor whose work in antibody-drug conjugates has made a lasting impact on biotechnology. His contributions continue to shape the future of medical treatments and therapies.